Total Funding
4
1
Total FundingVenture - Series Unknown raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
645162
BioMedomics develops advanced quantitative point-of-care (POC) diagnostic platforms and disease-specific diagnostic tests.
Acquired by 
OraSure Technologies
Frank Wang: Co-Founder & CEO
About the Company
BioMedomics, Inc. manufactures and markets bioscience products and medical devices. The company’s products includes deoxyribonucleic acid research reagents; human, mouse, and rat genepool products; tissue array products; and antibodies. It designs and develops real-time cell electronic sensing technology for analyzing cell-based assay procedures.
The company offers contract assay services such as cell proliferation, cytotoxicity, adhesion, viability, and invasion. Additionally, it provides drug discovery, research, and development services. BioMedomics is based in Research Triangle Park, North Carolina.
